The Ministry of Health and Welfare and the Korea Health Information Service recently helped connect researchers and hospitals as part of its initiative to promote data utilisation for medical research. WHAT IT’S ABOUT
In support of…
On August 31, the Office of California Healthcare Affordability (OCHA) will close the public comment period regarding proposed regulations under a new law that is aimed at providing oversight of certain healthcare M&A deals…
Continue Reading
M&A activity in the healthcare sector continued to decline in the second quarter of 2023, with the number of deals reaching its lowest point in three years, according to a new report from KPMG….
Continue Reading
From January to December 2022, the EMR market in the US has continued to move at a healthy click. Most of the energy that KLAS is seeing is happening in the small hospital space….
Continue Reading
The healthcare industry faced several headwinds in the last year, such as higher interest rates, more antitrust regulatory review concerns, higher valuations and recession worries. But despite these headwinds, health services deals “remained resilient”…
Continue Reading
A tale of two markets: on one side we have layoffs, sinking stock prices, and all sorts of trouble, but on the other side we've got some good bills passed and some pretty great…
Continue Reading
It's that time of the year! Summer is over and it's conference season! The Rock Health Summit was a fun session, the highlight of which was diversity, equity, inclusion, and representation. Tune in for…
Continue Reading
There are surprise profits in an overfunded sector, but then there are funding deals for staffing company Incredible Health ($80m), voice recorder Abridge ($12m), meditation company Interaxxon (Muse Headband) ($9m), medication company Arine ($29)…
Continue Reading
On this episode of Health Tech Deals, Jess pulls through with a terrible cold! It's the dog days of summer, and in addition to wishing she feels better, we also review some "sick" deals:…
Continue Reading
On this episode of HTD, Jess and I check out Akili Interactive: at least it's still worth more than Pear Therapeutics. And by the way, what do we think will happen between Amazon and…
Continue Reading
